This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schecter, R. L. Articles by Batist, G. Search for Related Content PubMed PubMed Citation Articles by Schecter, R. L. Articles by Batist, G.

Expression of a Rat Glutathione-S-transferase Complementary DNA in Rat Mammary Carcinoma Cells: Impact upon Alkylator-induced Toxicity¹

Lady Davis Research Institute, Sir Mortimer B. Davis Jewish General Hospital and McGill University, Montreal, Quebec, Canada [R. L. S., M. A. A-J., A. W., G. B.], and McArdle Laboratory, University of Wisconsin, Madison, Wisconsin [W. E. F.]

The role of glutathione-S-transferase (GST) in alkylator drug resistance has been studied in MatB rat mammary carcinoma cells. A series of GST transfectant cell lines was established by using an expression vector containing the complementary DNA for the rat GST Yc gene under regulation of the SV40 early region promoter and the antibiotic resistance plasmid pSV2neo. Transfectant cell lines expressing up to 4-fold higher total GST activity than in the parental wild type cell line were identified. Southern blot analysis confirmed a DNA fragment corresponding in size to the transfected GST Yc complementary DNA. Wild type MatB cells contain very low levels of Yc protein, whereas the Yc⁺ clones showed greatly increased amounts of the Yc subunit. The effect of increased GST Yc activity on the sensitivity of the transfected clones to various cytotoxic agents was assessed by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell survival assay. The clones expressing recombinant GST Yc were more resistant to melphalan (6- to 12-fold), mechlorethamine (10- to 16-fold), and chlorambucil (7- to 30-fold). In late passage populations of the GST Yc⁺ clones that had been grown over a period of 14 months under continuous selection in G418, GST activity was decreased and it was paralleled by a decrease in Yc protein. These late passage clones with diminished GST Yc content also demonstrate a partial reversion toward the wild type phenotype as determined by cytotoxicity assays using melphalan, mustargen, and chlorambucil. Interstrand DNA cross-links induced by mechlorethamine were significantly lower at 0, 2, and 20 h posttreatment in one of the GST Yc⁺ clones when compared to wild type MatB cells. These studies indicate that GST Yc overexpression can confer resistance to alkylating agents and that this correlates with inhibition of DNA cross-link formation.

¹ This work was supported by a grant from the National Cancer Institute of Canada (G. B.) and by a Grant (Ca-42066 from the NIH to W. F.).

² To whom requests for reprints should be addressed, at Department of Oncology, Jewish General Hospital, 3755 Cote Ste-Catherine Road, Montreal, Quebec, H3T 1E2 Canada.

Received 4/ 1/93. Accepted 8/ 9/93.

This article has been cited by other articles:

				L. Panasci, J.-P. Paiement, G. Christodoulopoulos, A. Belenkov, A. Malapetsa, and R. Aloyz Chlorambucil Drug Resistance in Chronic Lymphocytic Leukemia: The Emerging Role of DNA Repair Clin. Cancer Res., March 1, 2001; 7(3): 454 - 461. [Abstract] [Full Text]

				N. Saadane, L. Alpert, and L. E. Chalifour TAFII250, Egr-1, and D-type cyclin expression in mice and neonatal rat cardiomyocytes treated with doxorubicin Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H803 - H814. [Abstract] [Full Text] [PDF]

				C. S. Morrow, P. K. Smitherman, S. K. Diah, E. Schneider, and A. J. Townsend Coordinated Action of Glutathione S-Transferases (GSTs) and Multidrug Resistance Protein 1 (MRP1) in Antineoplastic Drug Detoxification. MECHANISM OF GST A1-1- AND MRP1-ASSOCIATED RESISTANCE TO CHLORAMBUCIL IN MCF7 BREAST CARCINOMA CELLS J. Biol. Chem., August 7, 1998; 273(32): 20114 - 20120. [Abstract] [Full Text] [PDF]

				I. Jaitovitch-Groisman, N. Fotouhi-Ardakani, R. L. Schecter, A. Woo, M. A. Alaoui-Jamali, and G. Batist Modulation of Glutathione S-Transferase Alpha by Hepatitis B Virus and the Chemopreventive Drug Oltipraz J. Biol. Chem., October 20, 2000; 275(43): 33395 - 33403. [Abstract] [Full Text] [PDF]